Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July—August 2021

• Published in: Vaccine Vol. 41; no. 11; pp. 1808 - 1818
• Main Authors: Salvatore, Phillip P., Lee, Christine C., Sleweon, Sadia, McCormick, David W., Nicolae, Lavinia, Knipe, Kristen, Dixon, Tom, Banta, Robert, Ogle, Isaac, Young, Cristen, Dusseau, Charles, Salmonson, Shawn, Ogden, Charles, Godwin, Eric, Ballom, TeCora, Rhodes, Tara, Wynn, Nhien Tran, David, Ebenezer, Bessey, Theresa K., Kim, Gimin, Suppiah, Suganthi, Tamin, Azaibi, Harcourt, Jennifer L., Sheth, Mili, Lowe, Luis, Browne, Hannah, Tate, Jacqueline E., Kirking, Hannah L., Hagan, Liesl M.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 10-03-2023; Elsevier Limited; Elsevier Science
• Subjects: Coronaviruses; Correctional facilities; COVID-19; COVID-19 - epidemiology; COVID-19 - prevention & control; COVID-19 transmission; COVID-19 vaccines; Disease control; Disease Outbreaks; Disease transmission; Enrollments; Epidemics; Gene sequencing; Genomes; Humans; Hypothesis testing; Immunization; Imprisonment; Infections; Infectious disease outbreaks; Medical laboratories; Nose; Outbreaks; Polymerase chain reaction; Prisons; Public health; Quarantine; Reverse transcription; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Vaccination; Vaccines; Viral diseases; Virus shedding; Whole genome sequencing; United States > US; Texas; BOP; WGS; CDC; Vaccination; IQR; VTM; Virus shedding; Infectious disease outbreaks; Ct; RT-PCR; Correctional facilities; COVID-19 transmission; CSTE
• ISSN: 0264-410X; 1873-2518; 1873-2518
• DOI: 10.1016/j.vaccine.2022.11.045

The extent to which vaccinated persons who become infected with SARS-CoV-2 contribute to transmission is unclear. During a SARS-CoV-2 Delta variant outbreak among incarcerated persons with high vaccination rates in a federal prison, we assessed markers of viral shedding in vaccinated and unvaccinated persons.
Consenting incarcerated persons with confirmed SARS-CoV-2 infection provided mid-turbinate nasal specimens daily for 10 consecutive days and reported symptom data via questionnaire. Real-time reverse transcription-polymerase chain reaction (RT-PCR), viral whole genome sequencing, and viral culture was performed on these nasal specimens. Duration of RT-PCR positivity and viral culture positivity was assessed using survival analysis.
A total of 957 specimens were provided by 93 participants, of whom 78 (84 %) were vaccinated and 17 (16 %) were unvaccinated. No significant differences were detected in duration of RT-PCR positivity among vaccinated participants (median: 13 days) versus those unvaccinated (median: 13 days; p = 0.50), or in duration of culture positivity (medians: 5 days and 5 days; p = 0.29). Among vaccinated participants, overall duration of culture positivity was shorter among Moderna vaccine recipients versus Pfizer (p = 0.048) or Janssen (p = 0.003) vaccine recipients. In post-hoc analyses, Moderna vaccine recipients demonstrated significantly shorter duration of culture positivity compared to unvaccinated participants (p = 0.02). When restricted to participants without reported prior infection, the difference between Moderna vaccine recipients and unvaccinated participants was more pronounced (medians: 3 days and 6 days, p = 0.002).
Infectious periods for vaccinated and unvaccinated persons who become infected with SARS-CoV-2 are similar and can be highly variable, though some vaccinated persons are likely infectious for shorter durations. These findings are critically important, especially in congregate settings where viral transmission can lead to large outbreaks. In such settings, clinicians and public health practitioners should consider vaccinated, infected persons to be no less infectious than unvaccinated, infected persons.